Selected article for: "flow cytometry and functional analysis"

Author: Vidy, Aurore; Maisonnasse, Pauline; Da Costa, Bruno; Delmas, Bernard; Chevalier, Christophe; Le Goffic, Ronan
Title: The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition
  • Cord-id: xauekjrw
  • Document date: 2016_10_31
  • ID: xauekjrw
    Snippet: The influenza A virus (IAV) PB1-F2 protein is a virulence factor contributing to the pathogenesis observed during IAV infections in mammals. In this study, using a mouse model, we compared the host response associated with PB1-F2 with an early transcriptomic signature that was previously associated with neutrophils and consecutively fatal IAV infections. This allowed us to show that PB1-F2 is partly involved in neutrophil-related mechanisms leading to death. Using neutropenic mice, we confirmed
    Document: The influenza A virus (IAV) PB1-F2 protein is a virulence factor contributing to the pathogenesis observed during IAV infections in mammals. In this study, using a mouse model, we compared the host response associated with PB1-F2 with an early transcriptomic signature that was previously associated with neutrophils and consecutively fatal IAV infections. This allowed us to show that PB1-F2 is partly involved in neutrophil-related mechanisms leading to death. Using neutropenic mice, we confirmed that the harmful effect of PB1-F2 is due to an excessive inflammation mediated by an increased neutrophil mobilization. We identified the downstream effects of this PB1-F2-exacerbated neutrophil recruitment. PB1-F2 had no impact on the lymphocyte recruitment in the airways at day 8 pi. However, functional genomics analysis and flow cytometry in broncho-alveolar lavages at 4 days pi revealed that PB1-F2 induced a NK cells deficiency. Thus, our results identify PB1-F2 as an important immune disruptive factor during the IAV infection.

    Search related documents:
    Co phrase search for related documents
    • activation recruitment and adaptive immunity: 1, 2, 3, 4, 5
    • activation state and acute pathology: 1, 2
    • activation state and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • acute model and ad libitum: 1
    • acute model and adaptive immunity: 1, 2, 3
    • acute model and adenoviral vector: 1
    • acute pathology and adaptive immunity: 1
    • adaptive immunity and adenoviral vector: 1